Reframing Benign Prostatic Hyperplasia as a Cardiometabolic Condition: Should BPH Be Considered a Metabolic Disease?
Reviews in Cardiovascular Medicine · 17.07.2026 · 27 (7)
DOI: 10.31083/rcm52887 ↗Kurz gefasst
Editorial in der Zeitschrift Reviews in Cardiovascular Medicine, online erschienen am 17.07.2026. Verfasst von Ioanna Dimitriadou und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nursing, University of Thessaly, 41500 Larisa, Greece. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Nursing, University of Thessaly, 41500 Larisa, Greece.
- Urology Department, Aristotle University of Thessaloniki, Papageorgiou General Hospital, 56429 Thessaloniki, Greece.
ORCID-Profile: Ioanna Dimitriadou, Michael Samarinas
Zitieren
APA
Dimitriadou, I., & Samarinas, M. (2026). Reframing Benign Prostatic Hyperplasia as a Cardiometabolic Condition: Should BPH Be Considered a Metabolic Disease?. Reviews in Cardiovascular Medicine, 27(7). https://doi.org/10.31083/rcm52887
Vancouver
Dimitriadou I, Samarinas M. Reframing Benign Prostatic Hyperplasia as a Cardiometabolic Condition: Should BPH Be Considered a Metabolic Disease?. Reviews in Cardiovascular Medicine. 2026;27(7). doi:10.31083/rcm52887
BibTeX
@article{Dimitriadou2026,
author = {Dimitriadou, Ioanna and Samarinas, Michael},
title = {Reframing Benign Prostatic Hyperplasia as a Cardiometabolic Condition: Should BPH Be Considered a Metabolic Disease?},
journal = {Reviews in Cardiovascular Medicine},
year = {2026},
volume = {27},
number = {7},
doi = {10.31083/rcm52887}
}
EUVIMED